NANIPRUS

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug NANIPRUS contains one active pharmaceutical ingredient (API):

1 Nitroprusside
UNII EAO03PE1TC - SODIUM NITROPRUSSIDE

The principal pharmacological action of nitroprusside is relaxation of vascular smooth muscle and consequent dilation of peripheral arteries and veins. Other smooth muscle (e.g. uterus, duodenum) is not affected. Nitroprusside is more active on veins than on arteries.

Read about Nitroprusside

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C02DD01 Nitroprusside C Cardiovascular system → C02 Antihypertensives → C02D Arteriolar smooth muscle, agents acting on → C02DD Nitroferricyanide derivatives
Discover more medicines within C02DD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1828740
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1009995, 1083609

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈